Categories: Latest

Indian pharma companies should increase base of sales in next few years: Nirmal Bang

New Delhi, June 21, 2017: Formulations plant of Dr Reddy’s Laboratories at Srikakulam gets inspected and gets 1 observation from United States Foods and Drug Authority (US-FDA). The plant was inspected with zero observations last time.

In an interview to CNBC-TV18, Vishal Manchanda, Pharma Analyst at Nirmal Bang spoke about the same.

He expects the company to resolve this observation in some time like they have been able to resolve the observations at Miryalaguda in the short time.

Entire sector is in a stage of transition and they need to scale up from here, he said.

“2018-2019 is when we will see the efforts from research and development (R&D) fructifying and delivering complex dosage forms in terms of approvals. Once these things are in place, all companies are set for a new growth trajectory. From a billion dollar to a USD 2 billion base would be the next rally for Indian pharma companies and that should be accomplished in the next four-five years,” said Manchanda.

Speaking about Aurobindo Pharma, he said, the company has surprised by delivering complex approvals. He expects to see such surprises from other companies.

A large part of the approvals expected are in to the price for Cadila Healthcare, he added.

He also expects Natco Pharma to stabilise once Copaxone approval comes through. He sees upside in the stock from current levels.

Dr Reddy’s Laboratories is Manchanda’s top pick in the pharma sector followed by Cipla and Aurobindo Pharma.

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

18 hours ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

18 hours ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago